John Leaman

Insider Reports History

Entity
Individual
Location
555 California Street, Suite 365, San Francisco, CA
Signature
/s/ John Leaman, M.D.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John Leaman:

Stock Role Class Num Shares Value Price $ Report Date Ownership
IMPEL PHARMACEUTICALS INC Chief Fin. & Business Officer Stock Option (right to buy) 70K Feb 14, 2023 Direct

Insider Reports Filed by John Leaman

Symbol Company Period Transactions Value $ Form Type Date Filed Role
IMPL IMPEL PHARMACEUTICALS INC Feb 14, 2023 1 $0 4 Feb 16, 2023 Chief Fin. & Business Officer
IMPL IMPEL PHARMACEUTICALS INC Dec 31, 2022 3 -$13.6K 4 Jan 4, 2023 Chief Fin. & Business Officer
IMPL IMPEL NEUROPHARMA INC Jan 26, 2022 1 $0 4 Jan 28, 2022 Chief Fin. & Business Officer
IMPL IMPEL NEUROPHARMA INC Oct 19, 2021 1 $0 4 Oct 21, 2021 Chief Fin. & Business Officer
IMPL IMPEL NEUROPHARMA INC Jul 20, 2021 1 $0 4 Jul 26, 2021 Chief Financial Officer